| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10299100 | European Neuropsychopharmacology | 2015 | 9 Pages |
Abstract
ECS decreased the binding of α2-adrenoceptors in cortical regions in the FSL and cortical and amygdaloid regions in the control FRL rats compared to their respective sham treated group. The normal SD controls showed no significant response to ECS treatment. Our data suggest that the therapeutic effect of ECS may be mediated through a decrease of α2-adrenoceptors, probably due to a sustained increase in noradrenaline release. These data confirm the importance of the noradrenergic system and the α2-adrenoceptor in depression and in the mechanism of antidepressant treatments.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Thea P. Lillethorup, Peter Iversen, Jesper Fontain, Gregers Wegener, Doris J. Doudet, Anne M. Landau,